# IV DEXAMETHASONE VS. METHYLPREDNISOLONE IN CHILDREN WITH SEVERE ASTHMA EXACERBATION

> **NCT07731217** · PHASE4 · COMPLETED · sponsor: **Istanbul Medeniyet University** · enrollment: 129 (actual)

## Conditions studied

- Status Asthmaticus
- Asthma (Diagnosis)
- Asthma Exacerbations

## Interventions

- **DRUG:** Intravenous Dexamethasone
- **DRUG:** Intravenous Methylprednisolone

## Key facts

- **NCT ID:** NCT07731217
- **Lead sponsor:** Istanbul Medeniyet University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-07-15
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2026-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07731217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07731217, "IV DEXAMETHASONE VS. METHYLPREDNISOLONE IN CHILDREN WITH SEVERE ASTHMA EXACERBATION". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07731217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*